Patients’ Attitudes Toward Hallucinogenic and Non-Hallucinogenic Psilocybin for Mental Health Treatment
Journal of Psychoactive Drugs May 29, 2025 Araam Abboud, Kyle Hua, Hannah Redding et al. 1 citation
A survey of psychiatric patients at a community mental health center found that 62.4% were open to hallucinogenic psilocybin therapy and 60.4% to non-hallucinogenic forms. Patients with major depressive disorder preferred hallucinogenic therapy, while those with borderline personality disorder or post-traumatic stress disorder favored non-hallucinogenic options, possibly due to concerns about the intensity of hallucinogenic experiences. Individuals with substance use disorder showed greater acceptance of both forms than those without. The findings suggest societal stigma is not a major barrier to psilocybin therapy and that non-hallucinogenic forms may offer a more accessible option for some groups.